强心复脉饮治疗慢性心力衰竭合并室性早搏临床观察

目的:观察强心复脉饮对慢性心力衰竭合并室性早搏临床疗效。方法:将75例慢性心力衰竭合并室性早搏患者按2∶1随机分为治疗组(50例)和对照组(25例),两组均采用硝酸酯类、血管紧张素换酶抑制剂、β受体阻滞剂、利尿剂、强心剂等常规治疗。对照组同服生脉饮口服液,治疗组则同服强心复脉饮,共治疗45天。结果:心功能疗效治疗组总有效率88%,对照组为64%,治疗组明显优于对照组(P<0.05)。室早疗效治疗组总有效率74%,对照组为48%,治疗组显著优于对照组(P<0.05)。中医证候疗效治疗组总有效率92%,对照组为68%,治疗组亦明显优于对照组(P<0.05)。结论:强心复脉饮可改善心衰和控制室早。

Clinical Observation of Qiangxin Fumai Decoction on Treatment of Premature Ventricular Contractions in Patients with Chronic Heart Failure

Objective:To investigate the effect of Qiangxin Fumai Decoction on treatment of premature ventricular contractions(PVC)in patients with chronic heart failure(CHF).Methods:75 patients of PVC with CHF were randomly divided into treatment group(50 patients)and control group(25 patients)in accordance with proportion of 2 to 1.Based on conventional treatments of nitrates,angiotensin-exchange inhibitors,β-blockers,diuretics and cardiac,the control group were treated with Shengmai Decoction,and the treatment group took Qiangxin Fumai Decoction for 45 days.Results:The total effective rate of cardiac function was 88% in the treatment group,and 64% in the control,there was a significant difference(P<0.05).The total effective rate of PVC treatment was 74% in the treatment group and 48% in the control group respectively(P<0.05).The total effective rate of TCM syndromes was 92% in the treatment group and 68% in the control group respectively(P<0.05).Conclusion:Qiangxin Fumai Decoction can ameliorate the heat failure and control PVC.